Navigation Links
Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care:
Date:4/8/2008

Organization Will Address Increasing Concerns that Future Payment & Coverage Policies Could Negatively Impact the Frequency of Colonoscopy

Screening & Sedation Options

ANNAPOLIS, Md., April 8, 2008 /PRNewswire/ -- The National Coalition for Quality Colorectal Cancer Screening and Care, a 501(c) 6 not-for-profit association, announces the formation of a broad-based coalition dedicated to reducing the incidence of colorectal cancer through educational programs aimed at promoting colonoscopy screening and care options for patients in a safe and comfortable setting.

The Coalition, comprised of gastroenterologists, surgeons, primary care physicians, oncologists, anesthesiologists, patient advocacy groups, and concerned individuals, will support a sustained effort of advocacy, collaboration, research, and education geared towards key stakeholders, including the public. Coalition activities commenced in March as part of the National Colorectal Cancer Awareness Month.

"A primary goal of the new organization is to promote evidence-based standards of care in a variety of medical practices that yield better clinical outcomes," notes Steven J. Morris, MD FACP FACG, Chairperson of the Coalition and CEO of Atlanta Gastroenterology Associates. In addition, Dr. Morris adds that "the Coalition wants to ensure that quality is never compromised by minimizing physician input or by the arbitrary efforts of insurer to save dollars at the expense of human lives." Dr. Morris recently accepted the nomination to head up the National Coalition for Quality Care and Cancer Screening and Care as its first Board Chairperson.

As reported by the American Cancer Society, colorectal cancer remains the second leading cause of cancer deaths. This year almost 150,000 Americans will be diagnosed with colorectal cancer and over 56,000 will die from this cancer. Colorectal cancer is one of the most treatable cancers if it is detected early, and screening with colonoscopy, the gold standard, is an effective tool in the fight against this deadly disease.

Stanford Plavin, MD, Vice Chairperson of the Coalition and managing partner of Ambulatory Anesthesia of Atlanta, states: "It is tragic that many people avoid colorectal cancer screening due to fear or anxiety. Colorectal cancer screening can be achieved in an effective manner without discomfort. I encourage patients and providers to join us in this most important effort to maintain all effective options for colorectal cancer screening that will enable us to achieve higher screening rates and make a positive impact on cancer survival."

"In order to achieve a higher colorectal cancer screening rate, physicians must be able to choose optimal forms of sedation to encourage patients to undergo screening colonoscopies," elaborates Dr. Morris. He observes further that "75 percent of new colon cancer cases occur in persons with no known risk factors, regular colorectal cancer screenings are crucial to the prevention, early detection and successful treatment of this disease."

The Coalition will work from a broad perspective to establish public policy consensus on the importance of physician and patient choice necessary for sustained improvement in colorectal cancer screening rates. One of the first written comments submitted by the Coalition relates to a proposed medical policy by Blue Cross and Blue Shield of Tennessee regarding the use of anesthesia services for routine gastrointestinal endoscopy. A copy of the Coalition's letter to the health plan is available at http://www.preventingcolorectalcancer.org .

Membership categories have been identified for a full range of stakeholders. The Coalition is actively recruiting members to join the organization and serve on the Coalition's Board of Directors and other committees. Tax-deductible contributions also can be sent to the Coalition.

To learn more about the activities of The National Coalition for Quality Colorectal Cancer Screening and Care, please visit http://www.preventingcolorectalcancer.org . You also can contact the Coalition at (866) 461-9296 (toll free) or at info@preventingcolorectalcancer.org.

Headquartered in Annapolis, Maryland, the National Coalition for Quality Colorectal Cancer Screening & Care (http://www.preventingcolorectalcancer.org) has been established to preserve the tradition of safe, comfortable and quality- based medicine. The mission of the Coalition is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer through maintaining screening and care options for patients.


'/>"/>
SOURCE National Coalition for Quality Colorectal Cancer Screeningand Care
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. National Non-Profit Organization Offers Free Mental Health Services to Military and Military Families
2. Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
3. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
4. Non-Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans
5. Teen Pregnancy Epidemic Another Reason for Women to Carry Condoms. Just in Case, Inc. Announces 10,000 Chic Condom Compact Give-Away to Womens Non-Profits Nationwide.
6. Senior Citizens Bureau Empowers Todays Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates
7. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
9. Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
10. Genesee & Wyoming Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
11. Massbank Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: